Form 8-K - Current report:
SEC Accession No. 0001628280-25-001228
Filing Date
2025-01-13
Accepted
2025-01-13 07:07:18
Documents
38
Period of Report
2025-01-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K avtx-20250113.htm   iXBRL 8-K 25966
2 EX-99.1 ex-991_avalocorporatepre.htm EX-99.1 31384
6 GRAPHIC ex-991_avalocorporatepre001.jpg GRAPHIC 95041
7 GRAPHIC ex-991_avalocorporatepre002.jpg GRAPHIC 155697
8 GRAPHIC ex-991_avalocorporatepre003.jpg GRAPHIC 141549
9 GRAPHIC ex-991_avalocorporatepre004.jpg GRAPHIC 135014
10 GRAPHIC ex-991_avalocorporatepre005.jpg GRAPHIC 125395
11 GRAPHIC ex-991_avalocorporatepre006.jpg GRAPHIC 154888
12 GRAPHIC ex-991_avalocorporatepre007.jpg GRAPHIC 50419
13 GRAPHIC ex-991_avalocorporatepre008.jpg GRAPHIC 149789
14 GRAPHIC ex-991_avalocorporatepre009.jpg GRAPHIC 128368
15 GRAPHIC ex-991_avalocorporatepre010.jpg GRAPHIC 138225
16 GRAPHIC ex-991_avalocorporatepre011.jpg GRAPHIC 141105
17 GRAPHIC ex-991_avalocorporatepre012.jpg GRAPHIC 131858
18 GRAPHIC ex-991_avalocorporatepre013.jpg GRAPHIC 181859
19 GRAPHIC ex-991_avalocorporatepre014.jpg GRAPHIC 161852
20 GRAPHIC ex-991_avalocorporatepre015.jpg GRAPHIC 178869
21 GRAPHIC ex-991_avalocorporatepre016.jpg GRAPHIC 179608
22 GRAPHIC ex-991_avalocorporatepre017.jpg GRAPHIC 65121
23 GRAPHIC ex-991_avalocorporatepre018.jpg GRAPHIC 43834
24 GRAPHIC ex-991_avalocorporatepre019.jpg GRAPHIC 186326
25 GRAPHIC ex-991_avalocorporatepre020.jpg GRAPHIC 36147
26 GRAPHIC ex-991_avalocorporatepre021.jpg GRAPHIC 141586
27 GRAPHIC ex-991_avalocorporatepre022.jpg GRAPHIC 37526
28 GRAPHIC ex-991_avalocorporatepre023.jpg GRAPHIC 31075
29 GRAPHIC ex-991_avalocorporatepre024.jpg GRAPHIC 113901
  Complete submission text file 0001628280-25-001228.txt   4194432

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT avtx-20250113.xsd EX-101.SCH 1850
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT avtx-20250113_lab.xml EX-101.LAB 21026
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT avtx-20250113_pre.xml EX-101.PRE 12041
40 EXTRACTED XBRL INSTANCE DOCUMENT avtx-20250113_htm.xml XML 2625
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Filer) CIK: 0001534120 (see all company filings)

EIN.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37590 | Film No.: 25524772
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)